The FDA's top regulator of cancer drugs interceded in a review of a Replimune skin cancer therapy, contributing to its ...

The FDA will soon require prescription opioid manufacturers to include stronger language on the medications’ label warning ...

The FDA's top regulator of cancer drugs played a key role in the rejection of a skin cancer therapy from Replimune Group, ...

Why pharma companies' "price transparency" reports paint a murky picture of how much Americans spend on prescription drugs.

Many San Diego biotech firms are struggling to raise money, with the uncertainty exacerbated by the Trump administration’s ...

The prelude to a transplant. A pause before a treatment plan can proceed. For every person in it, the waiting demands a balance between holding on and letting go.

NIH plans to shrink the share of grant applications it will award for the remainder of the fiscal year, in some cases by more ...

I understand the heartbreak of watching someone you love spiral. But compassion cannot mean locking people up,” writes a STAT ...

The introduction of GLP-1s for weight loss has been a dysfunctional mess, thanks to pharmaceutical companies, insurance plans ...

An advocacy group is suing the Trump administration for failing to disclose details of a settlement with Gilead over patent ...

Kevin Hall can speak freely now. The leading U.S. authority on the science of ultra-processed foods made headlines this ...

President Trump escalated his demands that pharma firms lower U.S. prices in line with what other countries pay, sending ...